Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CHANTAL Pharmaceutical -- Ignore unavailable to you. Want to Upgrade?

To: Norrin Radd who wrote (1132)	11/17/1997 10:13:00 PM
From: PACKRATCAT	Respond to of 1169

Results and news. Matthew Chantal Pharma CFO Lamprecht Leaves Co.; Names Scalzo CFO Chantal Pharma Says Four Directors Resign Chantal Pharm Relocates Headquarters To NY From Los Angeles Chantal Pharma Results -2: 1Q Financial Table Chantal Pharmaceutical Corp. - New York 1st Quar Sept. 30: 1997 1996 Revenues a $919,580 $1,909,636 Net income (1,619,818) (2,055,099) Avg shrs 18,385,871 18,190,516 Shr earns Net income (.09) (.11) Figures in parentheses are losses. a. Excludes $932,000 established as an allowance against accounts receivable from U.S. distributor Stanson Marketing Inc., corresponding to a portion of the accounts receivable owed to Stanson by its customers, which are overdue. Chantal Pharmaceutical Corp. (CHTL) markets cosmetics products. "Dow Jones News Service" "Copyright(c) 1997, Dow Jones & Company, Inc."